Metastatic Acral Lentiginous Melanoma
1 clinical trials · Condition
◉ Watch Metastatic Acral Lentiginous Melanoma
| Record | Firm | Date |
|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
Track Metastatic Acral Lentiginous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.